Fig. 7
Percent inhibition of metastatic nodule formation in B16F10-injected C56BL/6 mice after treatment with plain ETO and micellar formulations at a dose of 2 mg/kg. Results are the mean ± SD, n = 5 (**P < 0.01, ***P < 0.001 compared with ETO)
Fig. 7 | Cancer Nanotechnology